DAIC

OCTOBER 1, 2024

Food and Drug Administration (FDA) for its PlaqueIQ imaging analysis software to help physicians diagnose cardiovascular disease (CVD). Elucid has announced it received 510(k) clearance from the U.S. Hafiane, Vulnerable plaque, characteristics, detection, and potential therapies , J. Cardiovasc. 6 (3) (2019).

Cardiovascular Disease 52

Cardiovascular Disease Plaque Quality of Life Myocardial Infarction 52

DAIC

APRIL 5, 2024

Shockwave is a leading, first-to-market provider of innovative intravascular lithotripsy (IVL) technology for the treatment of calcified CAD and PAD. IVL is a minimally invasive, catheter-based treatment for calcified arterial lesions, which can reduce blood flow and cause pain or heart attack.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

FEBRUARY 16, 2024

HeartRisk combines insights from HIPAA-compliant anonymized and aggregated clinical cardiovascular data obtained through Cardio Diagnostics’ Epi+Gen CHD and PrecisionCHD clinical tests, with industry and geographic data to enable real-time population-level cardiovascular disease (CVD) risk insights. Hospitals annually.

Chronic Disease 91

Chronic Disease Heart attacks Heart Attack Heart Disease 91

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. We are very excited to see our purpose-driven mission come to life, making advanced cardiac care accessible to more patients and working towards our goal of eliminating heart attacks.” “We

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

MARCH 20, 2024

Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.

Technology 111

Technology Coronary Artery Disease Patient Care Private Practice 111

DAIC

OCTOBER 4, 2024

2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heart failure. Nicholas S.

Heart Failure 52

Heart Failure Technology Heart Attack Heart attacks 52

Cardiomatics

OCTOBER 10, 2022

According to WHO , cardiovascular diseases are the leading cause of death worldwide. One country that is currently struggling to reduce the number of patients with heart diseases is the United Kingdom. million people living with a heart or circulatory disease. There are around 7.6

Heart attacks 52

Heart attacks Heart Attack Cardiovascular Disease COVID-19 52

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

SoftCath

MAY 22, 2021

Among numerous other disorders, patients suffering from cardiovascular diseases have the largest mortality rate. Where developing countries have somehow managed to provide treatment for their citizens suffering from cardiovascular diseases. The surge for patients requiring cardiovascular care is enormous.

COVID-19 52

COVID-19 Blood Clot Technology Cardiovascular Disease 52

GEMMS

JUNE 25, 2024

Understanding Cardiovascular Disease in Women Understanding cardiovascular disease in women involves recognizing unique risk factors such as hormonal changes and pregnancy-related complications, necessitating proactive care and awareness to manage and prevent heart disease effectively.

Heart Disease 52

Heart Disease Risk Factors Diet Chest Pain 52

DAIC

MAY 21, 2024

The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovascular disease (CVD), the leading cause of death and disability in the United States.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Cardiomatics

AUGUST 4, 2022

Technology provides us with more and more possibilities in many areas of life, including medicine. It is no longer just a future dream, but a new reality for clinicians and patients who can already benefit from new technologies. Cardiovascular diseases are a group of diseases of the heart and blood vessels.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Cerebrovascular Disease 52

DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

DAIC

APRIL 9, 2024

Participants who were given access to a 5 mg dose of rosuvastatin using this technology-assisted approach experienced a 35.5% LDL or “bad” cholesterol contributes to the development of fatty deposits in the arteries, which raises the risk of heart attacks, strokes and other forms of heart disease.

Cholesterol 52

Cholesterol Blood Pressure Heart Disease Research 52

The Beat Blog

APRIL 8, 2022

At Heartbeat, our collective experience over the last several years proves that this model is an optimal fit for a very wide range of cardiovascular conditions. However, thanks to the rapid pace of technological growth, many of those obstacles to accessing virtual treatment are rapidly disappearing.

Cardiogenic Shock 52

Cardiogenic Shock Blood Pressure Heart Attack Heart attacks 52

DAIC

MARCH 25, 2024

BE ACTIVE—about physical activity and how physical activity is enhanced in patients looking at financial incentivization as well as gamification, and what that does for physical activity with regards to patients who have MI and a high risk for cardiovascular disease.

Education 59

Education Cardiogenic Shock Heart Failure Plaque 59

Dr. Paddy Barrett

SEPTEMBER 19, 2023

A therapy that has been proven repeatedly to reduce the probability of heart attacks and strokes in multiple double-blind randomised controlled studies 1. 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. For patients who develop ‘brain fog’, etc. J Lipid Res.

Dementia 52

Dementia Cholesterol Biomarkers Coronary Artery Disease 52

Dr. Malcolm Kendrick

OCTOBER 30, 2024

This misinformation would have resulted in many thousands of people giving up their medication and suffering heart attacks and strokes as a result. Why do these attacks happen? If you launch a really venomous attack on one scientist, it tends to deter all the others. With thousands dying. At least some of it.

Cholesterol 145

Cholesterol Article Research Diet 145